Nexus Concordat Inc.
A Delaware C-Corporation. Holder of five provisional patent applications covering the AetherProtocols architecture, biology-native computation, and governed longitudinal physiological state reconstruction. The legal entity around the IP that everything else is built upon.
What we hold
Nexus Concordat Inc. owns the patent portfolio covering the architecture, the compiler, and the methodology. We do not operate consumer products. We license the architecture to operating subsidiaries who do.
Pharmacokinetic decay applied as attention mechanism. The patent that makes feelings fade like real ones.
The 34-head cascade architecture. Five-molecule rate equations as the first layer of state.
Cascade composition, audit chain integration, citation-defensible state.
The Scyla compilation language. Programs whose state evolves under real biological equations.
Calculation-grounded reconstruction of persistent physiological state with governed execution, provenance, uncertainty, replay, validation, and abstention boundaries. Provisional application received by the USPTO on September 20, 2026.
What is built on us
The IP we hold is the foundation under three operating surfaces. Each one licenses the architecture for a different domain.
Counsel · investor · regulatory resources
Documents below are publicly viewable but maintained for counsel, regulatory review, and investor diligence. Internal materials are gated separately.